management of relapse following allohsct in patients with aml and mds
Published 2 years ago • 211 plays • Length 2:47Download video MP4
Download video MP3
Similar videos
-
1:13
second-line treatment strategies for patients with relapsed dlbcl
-
3:37
the future of aml treatment
-
1:13
prevention, detection and treatment of aml relapse after allo-sct
-
2:45
continuity of care for patients with hematological predispositions to aml
-
5:11
the frontline treatment strategy for newly diagnosed aml
-
1:00
the role of non-covalent btk inhibitors in the treatment of non-hodgkin lymphoma
-
1:54
new developments in aml treatment
-
6:22
post-transplant maintenance for patients with aml
-
5:07
optimizing transplantation outcomes for patients with aml
-
1:19
new treatments for aml
-
1:58
maintenance therapy strategies to reduce relapse in aml
-
july 25, 2024 meeting of the oncologic drugs advisory committee (odac)
-
2:48
treatments to prevent relapse in aml
-
3:03
improving aml outcomes
-
2:27
predictors of outcomes in post-transplant patients with aml
-
3:07
developing guidelines for the management of infections following treatment with bispecifics
-
1:02
maintenance therapy following treatment for amyloidosis
-
4:49
novel transplant strategies in aml and the importance of reducing the risk of relapse in patients